Detected ·
Vivid Dx
$15M—
Vivid Dx raised a $15M seed round to accelerate its platform for rapid pathogen identification and antimicrobial susceptibility testing directly from blood, helping clinicians treat life-threatening bloodstream infections faster. The round was co-led by Oxford Science Enterprises and Cedars-Sinai.
- Website
- www.vivid-dx.com
- linkedin.com/company/vividdx
- Amount
- $15 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-29 12:05:30 UTC
- Signal ID
- c69206ad-2acd-49dd-9412-0e30a1d7124e
As the API returns it
{
"id": "c69206ad-2acd-49dd-9412-0e30a1d7124e",
"created_at": "2026-07-29T12:05:30.498296Z",
"company_name": "Vivid Dx",
"company_website_url": "www.vivid-dx.com",
"company_linkedin_url": "https://www.linkedin.com/company/vividdx",
"event_type": "funding",
"funding_amount": 15000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Vivid Dx raised a $15M seed round to accelerate its platform for rapid pathogen identification and antimicrobial susceptibility testing directly from blood, helping clinicians treat life-threatening bloodstream infections faster. The round was co-led by Oxford Science Enterprises and Cedars-Sinai.*"
}